A nationwide trend away from radical prostatectomy for Gleason Grade Group 1 prostate cancer

BJU Int. 2022 Mar;129(3):311-314. doi: 10.1111/bju.15656. Epub 2021 Dec 28.

Authors

Joseph B John¹, John Pascoe¹, Sarah Fowler², Thomas Walton³, Mark Johnson⁴, Benjamin Challacombe⁵, Andrew J Dickinson⁶, Jonathan Aning⁷, John S McGrath¹

Affiliations

¹ The Royal Devon and Exeter NHS Foundation Trust, Exeter, UK.
² British Association of Urological Surgeons (BAUS), The Royal College of Surgeons, London, UK.
³ Nottingham University Hospitals NHS Trust, Nottingham, UK.
⁴ Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle, UK.
⁵ Guy's and St Thomas' NHS Foundation Trust, London, UK.
⁶ University Hospitals Plymouth, Plymouth, UK.
⁷ North Bristol NHS Trust, Bristol, UK.

PMID: 34825460
DOI: 10.1111/bju.15656

No abstract available

MeSH terms

Humans
Male
Neoplasm Grading
Prostate
Prostate-Specific Antigen
Prostatectomy*
Prostatic Neoplasms* / surgery

Substances

Prostate-Specific Antigen